#subdermal drug delivery

Discover 2 curated intelligence briefings related to this specific topic.

The End of the Encounter: Why Value-Based Care is Killing the Copay
Health & Medicine

The End of the Encounter: Why Value-Based Care is Killing the Copay

The traditional healthcare model of charging per visit is collapsing. A new wave of outcome-based pricing is shifting the financial incentive from the quantity of care to the quality of the result, fundamentally changing how patients and providers interact globally.

Read Analysis
Semaglutide Just Targeted the Liver's Deadliest Scarring
Health & Medicine

Semaglutide Just Targeted the Liver's Deadliest Scarring

Recent Phase II data reveals semaglutide's ability to reduce liver scarring in patients with MASH, while Novo Nordisk bets billions on new delivery platforms to ensure long-term organ preservation.

Read Analysis